This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
APOA5 · Western blot design guide
Design a Western Blot for APOA5
Real validated APOA5 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-APOA5 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Last reviewed: May 2026 · Scientific review: Boster Bio technical team
APOA5 Western Blot Experimental Design Guide
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before running
| Expected band | ~41.2 kDa | |
| Observed band | ~45 kDa | |
| Gel | 10–12% | |
| Negative control | siRNA / KO lysate |
Important caveats
Reasons your observed band may differ from the expected size.
| PTM | Phosphorylated + Cleaved | |
| Caveat | Phosphorylation shifts apparent size | |
| Regulation | IFN-γ-induced | |
| Isoform | 1 isoform(s) |
Section 1
Real Curated APOA5 Western Blot Protocols
Literature-validated Western blot parameters for APOA5 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human Caco-2 , Lane 2: human HepG2 . After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-Apolipoprotein A V/APOA5 antigen affinity purified polyclonal antibody (Catalog # A01242-3) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for Apolipoprotein A V/APOA5 at approximately 45KD. The expected band size for Apolipoprotein A V/APOA5 is at 45KD |
| Gel % | 10–12% |
| Load | 30ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 45 kDa |
Section 2
What Is the Expected APOA5 Western Blot Band Size?
APOA5 has a 41.2 kDa calculated mass but is a secreted, signal-peptide-cleaved apolipoprotein that typically runs at ~45 kDa on Western blots.
| Single band at approximately 45 kDa in plasma, serum, or secreted-protein preparations | represents the mature, signal-peptide-cleaved form of APOA5 as seen on antibody QC blots |
| Little or no band in whole-cell lysate | APOA5 is a secreted protein, so it accumulates extracellularly rather than remaining in the intracellular pool |
| Band running modestly above the 41.2 kDa calculated mass | reflects the mature secreted protein after removal of the 23-residue signal peptide, not a glycosylation-driven shift since none is annotated |
| Single sharp band rather than a smear | APOA5 has no annotated N- or O-glycosylation sites, so no glycoform heterogeneity is expected |
| No higher-molecular-weight band near double the monomer mass | no inter-chain disulfide bonds are annotated, so APOA5 is not expected to form a covalent homodimer |
💡Expected APOA5 appearanceExpect a single ~45 kDa band, the mature secreted APOA5 after signal-peptide cleavage, running above its 41.2 kDa calculated mass with no glycosylation smear or disulfide-linked dimer.
| Predicted mass from UniProt (41.2 kDa) | sets the baseline theoretical size before any post-translational processing |
| Signal peptide cleavage (residues 1-23) | removes the N-terminal secretion signal, distinguishing the smaller mature protein from the full-length precursor |
| Secreted subcellular localization | shifts detectable protein into extracellular fractions such as plasma, serum, or conditioned media rather than whole-cell lysate |
| Absence of annotated glycosylation sites | prevents glycoform-driven smearing, so the mature protein should run as a single defined band |
| Absence of annotated inter-chain disulfide bonds | means no covalent homodimer band is expected at roughly twice the monomer mass |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | APOA5 is secreted and does not accumulate intracellularly in most cell types | test plasma, serum, or conditioned media instead of whole-cell lysate |
| Multiple bands | co-detection of the full-length precursor before signal-peptide cleavage alongside the mature secreted form | confirm reducing conditions and compare band positions against the ~45 kDa mature form versus the slightly larger precursor |
| Weak or no signal | APOA5 is a low-abundance plasma apolipoprotein and can be routed to lysosomal degradation via SORL1 interaction | increase loading amount or plasma volume and include a known-positive liver-derived or plasma sample |
| Broad smear instead of sharp band | incomplete dissociation from chylomicron, VLDL, or HDL lipoprotein particles | ensure thorough denaturation and delipidation with adequate SDS, reducing agent, and boiling before loading |
| Fragments below expected size | proteolytic degradation during sample handling or endosomal/lysosomal trafficking | add protease inhibitors, keep samples cold, and minimize freeze-thaw cycles |
Experiment evidence
Western blot images showing APOA5 band
A01242-3 · APOA5
← swipe / scroll for more images →
Real WB data behind the band-size expectations in this section.
Sample controls for APOA5 Western blot
🧪For positive controls for APOA5 in Western blot, you can use human plasma or serum, since HPA reports no tissue expression data for this gene and APOA5 is annotated as a secreted protein best captured in circulating fluid rather than a cell lysate.
Positive control: Human plasma/serum
Negative control: ubiquitously expressed; use siRNA knockdown or KO line
Loading controls: Run GAPDH and β-actin alongside a total-protein stain (e.g., stain-free gel, Ponceau S, or REVERT) as loading controls.
⚠️Feasibility: As a secreted protein with no HPA tissue expression data, whole-cell lysates from standard cell lines will likely show little to no signal, so conditioned medium or plasma/serum should be used to verify antibody specificity, and siRNA/KO validation is recommended in absence of a known negative tissue.
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|
Section 3
Advanced APOA5 Western Blot Tips
Deeper troubleshooting and optimisation questions for APOA5, answered from its protein features.
Why does APOA5 run near 45 kDa instead of 41 kDa?
The 41.2 kDa prediction is for the unprocessed precursor before removal of the 1-23 signal peptide. Mature secreted APOA5 should be slightly smaller, yet apolipoproteins with amphipathic coiled-coil regions routinely migrate slower than predicted on SDS-PAGE due to reduced SDS binding, so an apparent band near 45 kDa is expected and not evidence of a sizing problem.
Could phosphorylation change the apparent APOA5 band size?
APOA5 is annotated as a phosphoprotein with two modified residues. Phosphorylation adds only tens of daltons per site, far below standard SDS-PAGE resolution, so it will not visibly shift the band. If phospho-status matters, use Phos-tag gels or phospho-specific antibodies rather than relying on apparent molecular weight.
When is APOA5 expression or secretion induced?
APOA5 is a hepatocyte-secreted apolipoprotein central to chylomicron, VLDL, and HDL triglyceride metabolism. Hepatic and circulating levels vary with metabolic and fasting/feeding state, so plasma or liver lysate samples should be matched for feeding status and lipid handling before comparing band intensity across conditions.
How should blocking be optimized for APOA5 blots?
Since APOA5 is a secreted, lipid-associated protein typically probed in plasma or serum, use BSA rather than milk to avoid lipoprotein or casein interference with antibody binding. Delipidating or diluting serum samples before loading also reduces lipoprotein aggregate smearing that can obscure blocking efficiency.
What transfer method to use for APOA5 Western blot?
APOA5 has no disulfide bonds and a modest 41.2 kDa mass, so standard wet or semi-dry transfer onto PVDF or nitrocellulose is sufficient. No extended or high-percentage-gel transfer is needed, though serum/plasma samples benefit from slightly longer transfer times due to co-migrating lipoprotein particles.
How should APOA5 blots be normalized for quantitation?
Because APOA5 is secreted into plasma rather than retained intracellularly, actin or GAPDH are invalid loading controls for serum/plasma samples. Use a total-protein stain such as Ponceau S or REVERT, or an established serum reference protein, to normalize APOA5 signal across lanes.
What explains unexpected extra bands on APOA5 blots?
APOA5 has no disulfide bonds, so extra bands are unlikely to be reduction artifacts. Instead check for the uncleaved 41.2 kDa signal-peptide-containing precursor, coiled-coil-driven self-association or oligomers, or retained complexes with binding partners such as GPIHBP1 or SORL1 if lysis or denaturation was incomplete.
Boster reagents
Best APOA5 Western Blot Antibodies
BosterBio's APOA5 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Real WB data
Anti-Apolipoprotein A V/APOA5 Antibody Picoband®
Cat # A01242-3
Our recommended anti-APOA5 antibody represents a best-performing, well-cited reagent for Western blot, thoroughly validated and orthogonally cross-validated against negative tissue controls and complementary detection methods, delivering specific, reproducible, high-confidence APOA5 detection for your experiments.
Which to pick: Only one Boster antibody is catalogued for APOA5: A01242-3, which includes a genuine Western blot validation image on SDS-PAGE. With no alternative SKUs listed, A01242-3 is the straightforward choice for APOA5 Western blot experiments.
Source: BosterBio APOA5 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.
References
- UniProt Consortium. UniProt entry Q6Q788.
- Human Protein Atlas. APOA5 tissue expression.